Mark Ogden
2008
In 2008, Mark Ogden earned a total compensation of $351K as Acting Vice President, Finance and Principal Financial Officer at Enzon Pharmaceuticals.
Compensation breakdown
| Other | $351,006 |
|---|---|
| Total | $351,006 |
Ogden received $351K in other compensation, accounting for 100% of the total pay in 2008.
Rankings
In 2008, Mark Ogden's compensation ranked 7,499th out of 9,135 executives tracked by ExecPay. In other words, Ogden earned more than 17.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,499 out of 9,135 | 18th |
Division Manufacturing | 2,837 out of 3,436 | 17th |
Major group Chemicals And Allied Products | 650 out of 815 | 20th |
Industry group Drugs | 464 out of 597 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 84 out of 118 | 29th |
Source: SEC filing on April 8, 2011.
Ogden's colleagues
We found five more compensation records of executives who worked with Mark Ogden at Enzon Pharmaceuticals in 2008.
2008
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2008
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2008
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2008
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2008
Paul Davit
Enzon Pharmaceuticals